To sway shareholders on next week's chairman vote, Jamie Dimon's supporters say focus on the bank's bottom line. They're hoping you will miss some accounting moves that have significantly boosted profits.
FORTUNE -- Jamie Dimon likes to talk about JPMorgan Chase's fortress balance sheet. What's a little more shaky is the bank's income statement.
Next Tuesday, at its annual meeting in Tampa, JPMorgan (JPM) will reveal the results of a shareholder vote MOREStephen Gandel, senior editor - May 16, 2013 10:42 AM ET
* Scott Kupor: The case for dual-class stock
* Noah Smith: Of course hedge funds lose money
* Snapshot: JPMorgan shareholders lose vote visibility
* Deadly repeat: Sneaker factory collapses in Cambodia
* Morning Call: U.S. futures flat, gold tumbles, Europe climbs and Japan falls.
* Sharef & Sedlet: Hire like a startup
* Oprhan diseases: The business of rarity
* It's back: Signs of a Hong Kong IPO rebound
* Coming tonight: Big IPO for Tableau Software
* Josh Kosman: Holes showing in MOREDan Primack - May 16, 2013 7:01 AM ET
How well-heeled money to conservative tax exempts triggered confusion and chaos inside the IRS -- and why the big bucks may be likely to surge.
By Lynnley Browning
FORTUNE -- The Internal Revenue Service's effort to scrutinize conservative groups, many bankrolled by "shadow money" from Wall Street to Kansas to Las Vegas, has sparked a political firestorm. But the aftermath may ignite donations to the secretive entities by right-leaning corporations and MOREMay 16, 2013 5:00 AM ET
Tableau's venture capital backers getting ready for a monster return.
FORTUNE -- Tableau Software today increased the price range of its pending IPO to between $28 and $30 per share, meaning that it could raise upwards of $216 million when it prices tomorrow night. It had originally planned to price at between $23 and $26 per share.
And no one is happier about the bump than venture capital firm New Enterprise Associates, MOREDan Primack - May 15, 2013 1:47 PM ET
Traders mostly shrugged off the Bloomberg snooping story. Then many users were alarmed when they found out messages had been posted online -- it's where many of them conduct most of their business.
By Cyrus Sanati
FORTUNE -- Bloomberg LP must go further to ensure their customers' sensitive data is truly secure. The company dodged a bullet last week as traders on Wall Street and in the City of London shrugged MOREMay 15, 2013 12:32 PM ET
Sexual harassment case against VC firm can proceed.
FORTUNE -- Venture capital firm CMEA Capital has lost its motion to compel arbitration in a sexual harassment suit brought against it by three former female employees. The complaint, filed in March, also alleges racial harassment and retaliation.
The San Francisco Superior Court judge also agreed to seal compensation history of the three plaintiffs: Dawn-Shemain Weeks, Margaret Hines and Shannon Schlagenhauf. The defense is expected to MOREDan Primack - May 15, 2013 11:43 AM ET
Fewer Americans have a stake in the stock market, and unemployment may be preventing more from investing in equities.
FORTUNE – As U.S. stocks soar to new highs, economists argue the rally makes people feel richer. And when they think they're wealthier, the theory is that they'll spend more on everything from homes to cars and clothing.
The problem with that idea is fewer and fewer Americans actually have any stake in MORENin-Hai Tseng, Writer - May 15, 2013 11:36 AM ET
Actavis Inc. (NYSE: ACT) last week received and rejected a $15 billion-plus acquisition offer from rival pharma company Mylan Inc. (Nasdaq: MYL), according to Reuters. www.actavis.com
Alvine Pharmaceuticals, a San Carlos, Calif.–based developer of celiac disease therapeutics, has signed a global collaboration agreement with AbbVie (NYSE: ABBV) for an oral treatment that currently is in Phase 2 development. The deal includes a $70 million upfront cash payment, and the possibility of additional considerations. Alvine previously raised more MOREDan Primack - May 15, 2013 11:07 AM ET
DeLille Cellars, a Woodinville, Wash.-based winery, has raised an undisclosed amount of growth equity funding from Bacchus Capital Management. www.delillecellars.com
High Road Capital Partners and Charter Oak Equity have acquired The Crown Group Inc., a Warren, Mich.–based provider of coating services and solutions to the transportation, agriculture and general industrial end markets. The selling Baer family was advised by Quarton Partners. No financial terms were disclosed. www.thecrowngrp.com
H.I.G. Capital has acquired Freedom Finance Nordic, a prime consumer loan broker operating in MOREDan Primack - May 15, 2013 11:06 AM ET
Tokai Pharmaceuticals Inc., a Cambridge, Mass.-based developer of prostate cancer drugs, has raised $35.5 million in Series E funding. Return backers included Apple Tree Partners and Novartis Venture Funds. http://www.tokaipharmaceuticals.com
Privalia Venta Directa, a Spanish online private sales site, has raised €25 million in new VC funding. Sofina (Belgium) was joined by return backers Highland Capital Partners, General Atlantic, Insight Venture Partners, La Caixa Capital Risc, Index Ventures and Nauta Capital. The company previously raised MOREDan Primack - May 15, 2013 11:06 AM ET
|Bernanke's advice for college grads|
|The Winklevoss twins are Bitcoin bulls|
|Bloomberg's lazy Apple bias|
|Signs of new housing bubble in several areas|